IBDEI2SO ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44559,1,4,0)
 ;;=4^T38.3X6A
 ;;^UTILITY(U,$J,358.3,44559,2)
 ;;=^5049649
 ;;^UTILITY(U,$J,358.3,44560,0)
 ;;=T38.3X6S^^164^2208^4
 ;;^UTILITY(U,$J,358.3,44560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44560,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,44560,1,4,0)
 ;;=4^T38.3X6S
 ;;^UTILITY(U,$J,358.3,44560,2)
 ;;=^5049651
 ;;^UTILITY(U,$J,358.3,44561,0)
 ;;=T38.3X6D^^164^2208^5
 ;;^UTILITY(U,$J,358.3,44561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44561,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
 ;;^UTILITY(U,$J,358.3,44561,1,4,0)
 ;;=4^T38.3X6D
 ;;^UTILITY(U,$J,358.3,44561,2)
 ;;=^5049650
 ;;^UTILITY(U,$J,358.3,44562,0)
 ;;=T46.5X6A^^164^2208^9
 ;;^UTILITY(U,$J,358.3,44562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44562,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
 ;;^UTILITY(U,$J,358.3,44562,1,4,0)
 ;;=4^T46.5X6A
 ;;^UTILITY(U,$J,358.3,44562,2)
 ;;=^5051353
 ;;^UTILITY(U,$J,358.3,44563,0)
 ;;=T46.5X6D^^164^2208^10
 ;;^UTILITY(U,$J,358.3,44563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44563,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
 ;;^UTILITY(U,$J,358.3,44563,1,4,0)
 ;;=4^T46.5X6D
 ;;^UTILITY(U,$J,358.3,44563,2)
 ;;=^5051354
 ;;^UTILITY(U,$J,358.3,44564,0)
 ;;=T46.5X6S^^164^2208^11
 ;;^UTILITY(U,$J,358.3,44564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44564,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,44564,1,4,0)
 ;;=4^T46.5X6S
 ;;^UTILITY(U,$J,358.3,44564,2)
 ;;=^5051355
 ;;^UTILITY(U,$J,358.3,44565,0)
 ;;=T43.206A^^164^2208^6
 ;;^UTILITY(U,$J,358.3,44565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44565,1,3,0)
 ;;=3^Underdosing of Antidepressants,Init Encntr
 ;;^UTILITY(U,$J,358.3,44565,1,4,0)
 ;;=4^T43.206A
 ;;^UTILITY(U,$J,358.3,44565,2)
 ;;=^5050543
 ;;^UTILITY(U,$J,358.3,44566,0)
 ;;=T43.206S^^164^2208^7
 ;;^UTILITY(U,$J,358.3,44566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44566,1,3,0)
 ;;=3^Underdosing of Antidepressants,Sequela
 ;;^UTILITY(U,$J,358.3,44566,1,4,0)
 ;;=4^T43.206S
 ;;^UTILITY(U,$J,358.3,44566,2)
 ;;=^5050545
 ;;^UTILITY(U,$J,358.3,44567,0)
 ;;=T43.206D^^164^2208^8
 ;;^UTILITY(U,$J,358.3,44567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44567,1,3,0)
 ;;=3^Underdosing of Antidepressants,Subs Encntr
 ;;^UTILITY(U,$J,358.3,44567,1,4,0)
 ;;=4^T43.206D
 ;;^UTILITY(U,$J,358.3,44567,2)
 ;;=^5050544
 ;;^UTILITY(U,$J,358.3,44568,0)
 ;;=T43.506A^^164^2208^12
 ;;^UTILITY(U,$J,358.3,44568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44568,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
 ;;^UTILITY(U,$J,358.3,44568,1,4,0)
 ;;=4^T43.506A
 ;;^UTILITY(U,$J,358.3,44568,2)
 ;;=^5050651
 ;;^UTILITY(U,$J,358.3,44569,0)
 ;;=T43.506S^^164^2208^13
 ;;^UTILITY(U,$J,358.3,44569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44569,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
 ;;^UTILITY(U,$J,358.3,44569,1,4,0)
 ;;=4^T43.506S
 ;;^UTILITY(U,$J,358.3,44569,2)
 ;;=^5050653
 ;;^UTILITY(U,$J,358.3,44570,0)
 ;;=T43.506D^^164^2208^14
 ;;^UTILITY(U,$J,358.3,44570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44570,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
 ;;^UTILITY(U,$J,358.3,44570,1,4,0)
 ;;=4^T43.506D
 ;;^UTILITY(U,$J,358.3,44570,2)
 ;;=^5050652
 ;;^UTILITY(U,$J,358.3,44571,0)
 ;;=99201^^165^2209^1
